RS63978B1 - Fekalna mikrobiota za lečenje bolesnika kod kojih se vrši transplantacija hematopoetskih matičnih ćelija - Google Patents

Fekalna mikrobiota za lečenje bolesnika kod kojih se vrši transplantacija hematopoetskih matičnih ćelija

Info

Publication number
RS63978B1
RS63978B1 RS20230101A RSP20230101A RS63978B1 RS 63978 B1 RS63978 B1 RS 63978B1 RS 20230101 A RS20230101 A RS 20230101A RS P20230101 A RSP20230101 A RS P20230101A RS 63978 B1 RS63978 B1 RS 63978B1
Authority
RS
Serbia
Prior art keywords
sample
csh
transplantation
patient
fecal microbiota
Prior art date
Application number
RS20230101A
Other languages
English (en)
Serbian (sr)
Inventor
Mohamad Mohty
Harry Sokol
Original Assignee
Univ Sorbonne
Centre Nat Rech Scient
Inst Nat Sante Rech Med
Hopitaux Paris Assist Publique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59325347&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS63978(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Sorbonne, Centre Nat Rech Scient, Inst Nat Sante Rech Med, Hopitaux Paris Assist Publique filed Critical Univ Sorbonne
Publication of RS63978B1 publication Critical patent/RS63978B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
RS20230101A 2017-01-26 2018-01-26 Fekalna mikrobiota za lečenje bolesnika kod kojih se vrši transplantacija hematopoetskih matičnih ćelija RS63978B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1750629A FR3062063B1 (fr) 2017-01-26 2017-01-26 Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques
EP18702952.5A EP3573631B1 (fr) 2017-01-26 2018-01-26 Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques
PCT/EP2018/051941 WO2018138251A1 (fr) 2017-01-26 2018-01-26 Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques

Publications (1)

Publication Number Publication Date
RS63978B1 true RS63978B1 (sr) 2023-03-31

Family

ID=59325347

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20230101A RS63978B1 (sr) 2017-01-26 2018-01-26 Fekalna mikrobiota za lečenje bolesnika kod kojih se vrši transplantacija hematopoetskih matičnih ćelija

Country Status (20)

Country Link
US (1) US20200188450A1 (enExample)
EP (1) EP3573631B1 (enExample)
JP (1) JP7527109B2 (enExample)
KR (1) KR102517287B1 (enExample)
CN (1) CN110520141A (enExample)
AU (1) AU2018212530B2 (enExample)
CA (1) CA3051807C (enExample)
DK (1) DK3573631T3 (enExample)
ES (1) ES2937965T3 (enExample)
FI (1) FI3573631T3 (enExample)
FR (1) FR3062063B1 (enExample)
HR (1) HRP20230122T1 (enExample)
HU (1) HUE061155T2 (enExample)
IL (1) IL268237B (enExample)
LT (1) LT3573631T (enExample)
PL (1) PL3573631T3 (enExample)
PT (1) PT3573631T (enExample)
RS (1) RS63978B1 (enExample)
SI (1) SI3573631T1 (enExample)
WO (1) WO2018138251A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200038506A (ko) * 2017-08-07 2020-04-13 핀치 테라퓨틱스, 인코포레이티드 건강한 장 장벽을 유지 및 회복시키기 위한 조성물 및 방법
US20220023419A1 (en) * 2018-11-28 2022-01-27 The Council Of The Queensland Institute Of Medical Research Inhibiting inflammation
CN112375705A (zh) * 2020-11-12 2021-02-19 安徽燕婉健康科技有限公司 一种替代天然菌群的肠壁移植优势菌的制备方法及其应用
EP4386090A1 (en) * 2022-12-12 2024-06-19 Assistance Publique - Hôpitaux De Paris Method for determining and improving the potential efficacy of anticancer treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649719B1 (fr) * 1989-07-17 1993-08-27 Cerbio Sa Procede de protection et de conservation de micro-organismes notamment de bacteries
BR112013022927A2 (pt) * 2011-03-09 2016-12-06 Univ Minnesota composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
CN104918624A (zh) * 2012-11-26 2015-09-16 托马斯·朱利叶斯·波洛迪 恢复排泄物微生物群的组合物及其制造和使用方法
WO2016057671A1 (en) * 2014-10-07 2016-04-14 University Of Virginia Patent Foundation Compositions and methods for preventing and treating infection
ES3010296T3 (en) * 2014-11-25 2025-04-02 Memorial Sloan Kettering Cancer Center Intestinal microbiota and gvhd
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
FR3035328B1 (fr) * 2015-04-24 2019-08-23 Maat Pharma Procede de preparation d'un echantillon de microbiote fecal
US20180185421A1 (en) * 2016-08-29 2018-07-05 Tokyo Metropolitan Government Composition comprising fecal microbiota

Also Published As

Publication number Publication date
KR102517287B1 (ko) 2023-03-31
PL3573631T3 (pl) 2023-05-02
IL268237A (en) 2019-09-26
AU2018212530A1 (en) 2019-09-05
EP3573631A1 (fr) 2019-12-04
SI3573631T1 (sl) 2023-09-29
US20200188450A1 (en) 2020-06-18
AU2018212530B2 (en) 2022-06-23
CN110520141A (zh) 2019-11-29
PT3573631T (pt) 2023-01-24
ES2937965T3 (es) 2023-04-03
FR3062063B1 (fr) 2019-04-19
CA3051807A1 (fr) 2018-08-02
FI3573631T3 (fi) 2023-03-02
JP7527109B2 (ja) 2024-08-02
KR20190130563A (ko) 2019-11-22
FR3062063A1 (fr) 2018-07-27
HUE061155T2 (hu) 2023-05-28
JP2020506183A (ja) 2020-02-27
WO2018138251A1 (fr) 2018-08-02
HRP20230122T1 (hr) 2023-03-31
CA3051807C (fr) 2023-07-11
IL268237B (en) 2022-07-01
EP3573631B1 (fr) 2022-11-16
LT3573631T (lt) 2023-03-10
DK3573631T3 (da) 2023-01-30

Similar Documents

Publication Publication Date Title
CN107530280B (zh) 粪便微生物群样品的制备方法
CN108430481B (zh) 冻干粪便微生物群样品的方法
De Castro et al. Fecal microbiota transplant after hematopoietic SCT: report of a successful case
JP7527109B2 (ja) 造血幹細胞移植を受けている患者を治療するための便細菌叢
CN112805367A (zh) 用于治疗艰难梭菌的方法和组合物
CN104430303B (zh) 人外周血干细胞冻存液的配制及使用方法
CN112998009A (zh) Nk细胞冻存液及其制备方法和应用
US20200038459A1 (en) Composition comprising fecal microbiota
STOCKSCHLA¨ DER et al. Long‐term follow‐up of leukaemia patients after related cryopreserved allogeneic bone marrow transplantation
CN116058363A (zh) 一种增加nk细胞冻存复苏后活性的方法及其应用
Zhang et al. Clinical applications of haploidentical hematopoietic stem cell transplantation in severe aplastic anemia.
CA2668608A1 (en) Methods for using aldhbr cells to supplement stem cell transplantation
Cameron et al. Cryopreserved mobilized autologous blood progenitors stored for more than 2 years successfully support blood count recovery after high-dose chemotherapy
Sinitsyn et al. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization
Zhao et al. Effects of TNF alone or in combination with chemotherapeutic agents on human ovarian cancers in vitro and in nude mice
Lehn et al. Bone marrow transplantation for chronic granulocytic leukemia
Kebriaei et al. Inferior Outcome With Addition Of Rituximab For Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Acute Lymphoblastic Leukemia (ALL)
Storb Bone Marrow Transplantation for the Treatment of Leukemia
Lee et al. Cord Blood (CB) Extends Transplant Access to Racial and Ethnic Minorities: A Prospective Study of 309 Unrelated Searches in Patients with High-Risk Hematologic Malignancies
Storb Treatment of Acute Leukemia in Remission by Bone Marrow Transplantation
Litzow 15 Blood and Marrow Transplantation